RecruitingPhase 4NCT05770622

Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2)

Studying Young syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Murdoch Childrens Research Institute
Principal Investigator: Amanda Wilkins, MBBS
Royal Children's Hospital Melbourne, Murdoch Children's Research Institute
Intervention: First-dose trough dose adjustment calculator - using early TDM (first-dose trough) to determine an early dose adjustment if the predicted steady-state trough is outside of target range (10-20mg/L)(other)
Enrollment: 40 target
Eligibility: All sexes
Timeline: 2024 – 2026

Study locations (4)

Royal Children's Hospital Melbourne, Melbourne, Victoria, Australia
Monash Newborn, Melbourne, Australia
Royal Hospital for Women, Sydney, Australia
The Children's Hospital at Westmead, Sydney, Australia

Collaborators

Royal Children's Hospital · Royal Hospital For Women · Sydney Children's Hospitals Network · Monash Health

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05770622 on ClinicalTrials.gov

← Back to all trials